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Abstract 
The solute transport distribution in a tumor is an important criterion in the evaluation of the 
cancer treatment efficacy. The fraction of killed cells after each treatment can quantify the 
therapeutic effect and plays as a helpful tool to evaluate the chemotherapy treatment schedules. 















provided for calculation of interstitial fluid flow and solute transport. Current model incorporates 
heterogeneous microvasculature for angiogenesis instead of synthetic mathematical modeling. In 
this modeling process, a comprehensive model according to Convection-Diffusion-Reaction 
(CDR) equations is employed due to its high accuracy for simulating the binding and the uptake 
of the drug by tumor cells. Based on the velocity and the pressure distribution, transient 
distribution of the different drug concentrations (free, bound, and internalized) is calculated. 
Then, the fraction of killed cells is obtained according to the internalized concentration. Results 
indicate the dependence of the drug distribution on both time and space, as well as the 
microvasculature density. Free and bound drug concentration have the same trend over time, 
whereas, internalized and total drug concentration increases over time and reaches a constant 
value. The highest amount of concentration occurred in the tumor region due to the higher 
permeability of the blood vessels. Moreover, the fraction of killed cells is approximately 78.87% 
and 24.94% after treatment with doxorubicin for cancerous and normal tissues, respectively. In 
general, the presented methodology may be applied in the field of personalized medicine to 
optimize patient-specific treatments. Also, such image-based modeling of solid tumors can be 
used in laboratories that working on drug delivery and evaluating new drugs before using them 
for any in vivo or clinical studies. 
Keywords: Drug delivery, Solid tumor, Microvasculature, Image-based spatio-temporal model, 
Heterogeneous capillary network, Fraction of killed cells, Mathematical modeling. 
Introduction 
Cancer is one of the major public health problems all over the world (Zhang et al., 2014, 
2015). The key to successful cure of tumor is mostly an efficient delivery of anticancer drugs 















density of extracellular matrix (ECM), solid stress elevation/vessel compression, and leaky and 
irregularly shaped microvascular networks are the main reasons in decreasing the efficacy of 
drug delivery and treatment (Stylianopoulos et al., 2018; Dewhirst and Secomb, 2017). These 
barriers and also the lack of lymphatic system have contribution in high values of interstitial 
fluid pressure (IFP). Elevated IFP prevents the systematic drug delivery by an outward 
convection against inward drug diffusion (Stylianopoulos et al., 2018; Dewhirst and Secomb, 
2017; Jain and Baxter; 1988, Soltani and Chen, 2011). Each tumor has its own structure and 
physiochemical characteristics such as surface per volume of vasculatures, capillary networks 
pattern, and hydraulic conductivity to name a few. This makes drug delivery and therefore, 
treatment of solid tumor very complicated and case specific. On the other hand, quantitative 
prediction of drug delivery to solid tumor using patient-specific data is noteworthy in clinical 
decision for therapeutic planning (Meghdadi et al., 2016). The aim of mathematical modeling 
and simulation is to better understand the tumor behaviors which will ultimately improve the 
treatment outcome.  
Due to the multiple processes involved in drug delivery and tumor microenvironment 
complexity, mathematical modeling is an effective tool to find out the restriction agents of 
inefficient anti-cancer drug delivery. There exist two major methodologies to simulate delivery 
of drugs to solid tumors: macroscopic and microscopic. In the first approach, distribution of 
variables including interstitial fluid velocity (IFV), IFP, and drug concentration over the tumor 
radius length-scale is significant. In the second one, some characteristics such as microvascular 
network structure, blood flow within microvessels, and interaction between blood flow and 
microvascular wall are incorporated in the model. Following macroscopic approach, Baxter and 















of different factors on the drugs concentration in ECM of solid tumors. Soltani and Chen (2011, 
2013) improved the mathematical model and applied it to investigate two new parameters of 
spherical tumors: critical radius of the tumor and critical radius of the necrotic zone. Also, to 
study the shape and size effects of tumors on drug delivery, they applied the model to different 
geometries (Soltani, 2012; Soltani and Chen, 2012; Soltani et al., 2014). El-Kareh and Secomb 
(2005) and Eikenberry (2009) used a mathematical model tool to determine the drug 
concentration respectively in the extracellular and intracellular spaces of solid tumors. There 
exist many new efforts in mathematical modeling and simulation of drug delivery to solid 
tumors, in the literature (Pishko et al., 2011; Sefidgar et al., 2014a, 2014b, 2015, Asgari et al., 
2018; Soltani et al., 2017; Chou et al., 2017; Zhan and Xu, 2013; Zhan et al., 2014, 2017; 
Stylianopoulos et al., 2015; Mpekris et al., 2017; Steuperaert et al., 2017; Shamsi et al., 2018) to 
study the effect of different factors and parameters including IFP, IFV, capillary network, and 
concentration.  
Tumor microvasculature is blood vessels which provide nutrients, oxygen or glucose for 
growth of the tumor (Baxter and Jain, 1989). Various studies have been developed on the 
vascular structure and formation of the capillaries around the tumor. Most of these studies used a 
mathematical modeling to generate tumor microvasculature based on the work of Anderson et al. 
(1998, 2012). Anderson and Chaplain (1998) developed an angiogenesis model, in which new 
vessels began to grow from a parent vessel in keeping with a special probability calculated 
according to physiological conditions such as concentration of VEGF and density of endothelial 
cells. Welter et al. (2008, 2009, 2010) by considering some phenomena including co-option of 
adjacent vasculature to the tumor, growth of the tumor, and collapse of the vessels, developed 















capillary channels: a narrow constricted capillary and a leaky one. Recently, Stephanou et al. 
(2005), J. Wu et al. (2008), Welter and Rieger (2013), M. Wu et al. (2014), Sefidgar et al. 
(2015), and Soltani et al. (2017) simulated the drug delivery to solid tumors in the presence of 
heterogeneous microvasculature but their mathematical approach is not absolutely accurate and 
real. These models are helpful for investigating the interaction of various physiological 
phenomena within the tumor during drug transport; however, they cannot accurately predict the 
tumor behavior in a specific patient, as the tumor microenvironment changes widely from one 
case to another. Therefore, unlike these synthetic microvascular mathematical models, an 
imaged-based approach is employed to calculate the spatio-temporal distribution of the drug 
within the tumor in the present study.  
Medical images are the most common resources of clinical data which are used in 
personalized models. Recent computational fluid dynamics (CFD) methodologies for modeling 
the drug delivery to solid tumors have generated a novel domain of personalized clinical 
possibilities by integrating more patient-specificity with the medical imaging data. Some of these 
previously published investigations used magnetic resonance imaging (MRI) such as the works 
of Bhandari et al. (2018) and Tan et al. (2003) for brain tumor or Pishko et al. (2011) for mice 
tumor. No one of the literature studies used the image-based geometry of the capillary networks 
as their main geometry and instead, only the mathematical modeling has been used to generate a 
synthetic capillary network. Using image-based geometry for capillaries in CFD simulations, can 
help researchers to better understand in vivo model behavior. Nevertheless, capturing an image 
of the capillaries is one of the main challenges because of two major problems: first, the way of 
capturing an image of the capillaries with existent medical devices where their accuracy cannot 















CFD analysis. There exist several investigations and algorithms proposed to detect the 
microvasculature from an image which contain the capillary network and also, a noisy 
background, for example, single-scale and multi-scale matched filters (Chaudhuri et al., 1989; 
Zhang et al., 2010; Malek et al., 2015; Sofka and Stewar; 2005), single-scale and multi-scale 
Gabor filters (Rangayyan et al., 2007; Janko et al., 2005), and bar-selective combination of 
shifted filter responses (Strisciuglio et al., 2015). Abdallah et al. (2015) proposed a novel 
algorithm for detection of the retinal vascular tree which eliminate some noises in the image and 
connect discontinuity among the blood vessels.  
An image-based spatio-temporal solid tumor model can be applied to optimize and 
evaluate the treatment strategies for patient-specific therapies. In the current study, for the first 
time, a comprehensive approach for solving transport phenomenon of the chemotherapy, based 
on CDR equations, was combined with an image-based method to evaluate the drug delivery to 
solid tumor by considering the heterogeneous microvasculature network. The methodology is 
such that using an image-processing method, the tumor geometry was reconstructed from a 
previously obtained image, and then, the numerical simulations were performed. First, IFP and 
IFV were calculated in both microvascular network and interstitium, simultaneously. Then, 
different drug concentrations including free, bound, and internalized were obtained. Eventually, 
using the predicted intracellular drug concentration, the fraction of killed cells parameter was 
obtained and subsequently, anticancer drug efficacy and side effects of the drug on normal tissue 
were evaluated. This research provides a preliminary step forward towards the goal of 
personalized medicine. 
2. Materials and Methods 















in solid tumors. Mathematical modeling approach, image-processing procedure, model 
geometry, computational domain, boundary conditions, model parameters, solution strategy, and 
eventually grid independency test are investigated in the following sections. 
2.1. Mathematical modeling procedure 
The chemotherapy drugs (in this study, doxorubicin) are transmitted to the site of the 
tumor via the blood vessels. Then, they pass through the wall of the tumor vessel and after that, 
they travel the remaining distance from the vessel wall to the cancer cells. Free molecules of 
doxorubicin in tumor interstitial space can bind to receptors of the cell surface, unbind or get 
internalized (Soltani et al., 2017; Stylianopoulos et al., 2015). Fig. 1 represents the mentioned 
mechanisms of drug delivery considered in present study.  
 
Fig. 1. Schematic of the drug delivery mechanism considered in the present study 
The overall model for solute transport, which is called CDR model, consists of: drug 















space by diffusion and convection in tissue, and other mechanisms including drug binding to 
cancer cells and its internalization into the cells. Details of these equations are mentioned in the 
literature (Baxter and Jain, 1991; Sefidgar et al., 2015; Soltani et al., 2014, 2017; Stylianopoulos 
and Jain, 2013). This modeling is based on compartment models which are widely used to 
describe the drug delivery, as they are enable to quantify the biochemical and physiological 
phenomena (Soltani et al., 2017). In compartmental modeling, it is assumed that the 
concentration in each compartment is distributed independently. But, CDR equations supposed 
that the drug concentration in the second compartment is changing because of diffusion and 
convection processes and this is the difference between these two models (Soltani et al., 2017). 
In other words, the spatio-temporal distribution is added to the compartmental modeling in the 
present study. So, the drug distribution in compartments relies on both space and time. The 
block-diagram of the current study model is shown in Fig. 2. 
 
 
Fig. 2. Drug transport modeling of current study based on 5-K compartment model  
The equation system applied for the drug transport in interstitial space is as following 
(Soltani et al., 2017; Stylianopoulos et al., 2015): 
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 Internalized drug (3) 
where, CF, CB, and CINT are the free, bound, and internalized drug concentration, respectively. 
Crec is the concentration of cell surface receptors, v is the IFV obtained from Darcy's law, D is 
the coefficient of diffusion, KON, KOFF, and KINT are respectively the constants of association, 
dissociation, and internalization rate and also, φ is the volume fraction of tumor accessible to the 
drug. V  and L  are respectively the solute transport rates per unit volume from blood vessels 
into the interstitium (like a leakage from a capillary (Zhang, 2018)), and from the interstitium 
into the lymphatic vessels. These two parameters are obtained as following by Kedem-
Katchalsky equation (Curry, 1984; Jain, 1997): 
(1 ) ( )
1






















  (6) 
𝜙𝑉 is the source term expressed the extravasation from microvessels, and L  is the drainage term 
represented the elimination by the lymphatic system. These parameters are defined as bellows: 
( ( ))
pV


























In the modeling of fluid flow, three fronts are noteworthy: blood flow in microvessels, 
fluid flow in lymphatic systems, and fluid flow in interstitium. Fluid flow in tissue is considered 
in CDR equation. Here, the tissue is considered as a porous medium. For fluid transport in tissue, 
Darcy’s law is used. In the current study, the IFV is calculated by Darcy’s equation, as 
bellowing: 
i iv P    (9) 
while, the IFP is calculated as follows: 
2
i V LP       (10) 
The procedure of calculating the IFP is exactly explained in the previous works of our 
group (Soltani and Chen, 2013; Soltani et al., 2017). 
Using the predicted intracellular drug concentration (CINT), efficacy of anticancer drug 
and also, side effects of chemotherapy on normal tissue are evaluated according to the previously 
measured experimentally formulation for doxorubicin (Kerr et al., 1986). Results were fitted to 
an exponential expression as the function of CINT. In other words, SF is the fraction of surviving 
cells which is calculated as following (Mpekris et al., 2017): 
exp( )F INTS C    (11) 
in which, ω is a fitting parameter defined in literature (Kerr et al., 1986) for doxorubicin and CINT 
is the intracellular concentration of the doxorubicin.  
Summaries of model parameters of interstitial transport and also, solute transport for 


















Table 1 Interstitial transport parameters for tumor and normal tissue used in simulation  
Parameter Description Value References 
πb [mmHg] Capillary oncotic pressure 
20 (Normal) 
20 (Tumor) 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
𝜋𝑖 [mmHg] Interstitial fluid oncotic pressure 
10 (Normal) 
15 (Tumor) 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
(S/V)L [1/cm] 
Lymphatic surface area per unit 
volume for transport 
70 (Normal) 
20 (Tumor) 
Chou et al. (2017) 
σs Average osmotic reflection coefficient 
0.91 (Normal) 
0.82 (Tumor) 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
𝐿𝑝 [cm/((mmHg)*s)] 




Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
𝜅 [cm2/(mmHg*s)] Interstitium hydraulic conductivity 
8.53e-9 (Normal) 
4.13e-8 (Tumor) 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
 
Table 2. Solute transport parameters used in simulation 
Parameter Description Value References 
Deff  [cm
2
/s] Effective diffusion coefficient 
1.58e-6 (Normal) 
3.40e-6 (Tumor) 
Chou et al. (2017) & Zhan et 
al. (2014) 
Pm [cm/s] Microvessel permeability coefficient 
3.75e-5 (Normal) 
3.00e-4 (Tumor) 
Chou et al. (2017) & Zhan et 
al. (2014) 
σf Filteration reflection coefficient 0.9 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
KON [1/(M·s)] Constant of binding rate 1.5e3 
Stylianopoulos et al. (2015) & 
Stylianopoulos and Jain (2013) 
KOFF [1/s] Constant of unbinding rate 8e-3 
Stylianopoulos et al. (2015) & 
Stylianopoulos and Jain (2013) 
KINT [1/s] Constant of cell uptake rate 5e-5 
Stylianopoulos et al. (2015) & 
Stylianopoulos and Jain (2013) 
φ Tumor volume fraction accessible to drugs 0.4 Zhan and Xu (2013) 
Crec [M] Concentration of cell surface receptors 1e-5 Stylianopoulos et al. (2015) 
PL [Pa] Hydrostatic pressure of lymphatic vessels 0 
Soltani and Chen (2011) & 
Sefidgar et al. (2014a) 
ω [m
3
















2.2. Image-processing procedure of the input image 
The first step for the creation of the 2-dimensional geometry from an image consisted the 
capillaries, is image-processing which is consisted some crucial steps to improve the contrast and 
quality of input image. Basically, raw input RGB images have noises, low contrast, and 
homogeneous colors. Consequently, some image-processing techniques such as histogram 
equalization of color intensity and removing details by making a binary image (black and white 
image), must be taken into account to capture the microvasculature area from a background of 
the image more effectively. In the final step, the contour of the processed image is evaluated and 
the minimum values of them are used to create the closed surface from them which in reality is 
the capillaries. Step by step descriptions of image-processing procedure applied to input image 
are explained in Fig. 3. Furthermore, it is worth mentioning that due to the lack of availability of 
clinical image and data set with a high resolution, the synthetic image from the research of 
Welter et al. (2009) is employed in current study. In the study of Welter et al. (2009), each lattice 
site of the space occupied by a tumor is identified with one tumor cell. A lattice site which was 
occupied by a tumor cell in the past represents cancerous tissue, otherwise unoccupied sites 































2.3. Model geometry, computational domain, and boundary conditions 
After image-processing, computational domain is considered as 2-dimensional 
rectangular normal tissue with the dimension of 1.8 cm × 1.6 cm and tumor has the diameter of 1 
cm, as is shown in Fig. 4. Also, there exist three parent vessels which capillary network grows 
from them.  
In the current study, a bolus injection of chemotherapy drug is modeled so that the 
concentration at the inlet of the vascular network decreases exponentially, as bellowing (Sefidgar 
et al., 2015): 
Cp= exp (-t/Kd) (12) 
Kd is a time constant that describes the exponential decay in the blood and corresponds to the 
blood half-life. In this study, it is assumed that the process of drug delivery is modeled instantly 
after the drug distribution within the capillaries reached to uniform state. 
Due to having 2-dimensional geometry for capillary network, the pipe flow model (which 
is used for 1-dimensional geometries) cannot be used and therefore, blood flow is assumed to be 
modeled as a laminar flow (Asgari et al. 2018). For blood flow modeling, the pressure value of 
inlet and outlet parent vessels are as follows: 
PInlet,1 =25 mmHg PInlet,2 =25 mmHg POutlet,1 =10 mmHg 
For the boundary between tumor and normal tissue, continuity of the IFV, IFP, and also 





 demonstrate the tumor and normal tissue at the boundary. Boundary conditions 
of the presented investigations are outlined in Table 3. For outer boundary, where the interstitial 
pressure is constant; the boundary condition of Dirichlet-type must be applied (Soltani and Chen, 















Table 3. Boundary conditions employed for the present study 
Region 
                                Boundary condition 
Fluid flow Concentration 
Center of the tumor 0iP                 for r=0 0eff iD C v C            for r=0 
Inner boundary 
t i n ik P k P        
i iP P    
( ) ( )t neff i i eff i iD C v C C D C v C C        
i iC C    
Outer boundary Pi = Constant 0n C    
 
 
Fig. 4. Computational domain and boundary conditions of the current study which includes 
tumor, normal tissue, and microvascular network 
2.4. Solution strategy 















drug delivery to solid tumor is shown in Fig. 5. First, computational domain is generated based 
on the input image. Then, there is two different phases of the solution: steady-state phase and 
time-dependent one. Laminar intravascular flow, IFV, and IFP are modeled in steady-state phase. 
In time-dependent phase, by using the information achieved from the previous steps, drug 
concentrations (CF, CB, and CINT) and fraction of killed cells (SF) are modeled.   
 
Fig. 5. The flowchart used to describe the simulation procedure of drug delivery to solid tumor 
2.5. Grid independency test 















elements on the simulation results. The appropriate number of elements is chosen by a trade-off 
between the cost of computational resources and the results of numerical solution (Soltani et al., 
2019; Mehryan et al., 2018; Zargar et al., 2016). When the finer mesh does not change the 
numerical results significantly, the refined mesh is considered as suitable mesh (Soltani et al., 
2019, 2018). Five different versions of the computational mesh (coarse, normal, fine, finer, and 
extra fine) are created to evaluate the mesh independency. With fine mesh elements (which is 4 
times the initial number of mesh elements), less than 2% variation in simulated drug 
concentration and fluid flow parameters is found. By increasing the number of mesh elements to 
finer and extra fine (that is 8 and 16 times the initial number of mesh elements, respectively), 
almost no variation in the drug concentration and fluid flow parameters is observed. Therefore, 
the fine mesh elements due to the lowest computational costs are used for the whole simulation. 
It is worth mentioning that free triangular mesh is used in the current study for both normal and 
tumorous tissue as shown in Fig. 6. 
 















3- Results and discussion 
In the present study, an image-based solid tumor model employed for solving drug 
transport phenomenon based on CDR equations. Complex microvascular network adopted from 
three parent vessels are located within the tumor and normal tissue. In the following, the 
parameters of IFV, IFP, and concentration in tumor and normal tissue will be investigated in 
detail. 
The intravascular blood pressure (IBP) and IFP distributions are illustrated in Figs. 7 (a) 
and (b), respectively. In the capillary network, the ratio of minimum IBP to maximum IBP is 0.4. 
This is in a good agreement to the predicted values of Sefidgar et al. (2015) and Cai et al. (2011) 
which is reported 0.4 and 0.3, respectively. The higher amount of IBP has both favorable and 
unfavorable influences on drug delivery. Because on one side, it increases the convective rate of 
drug transport from vessels and on the other side, increases the transvascular flow which 
terminates to increase in IFP in tumor region as one of the main obstacles of drug delivery to the 
tumor.   
IFP in tumor and its surrounding tissue plays an important role in determining the 
convective drug transport between microvessels and interstitium driven by the gradient of 
transvascular pressure and also, drug convection in ECM. According to Fig. 7 (b), the IFP in 
tumor region has its highest value in comparison with normal tissue. The reason for elevated 
pressure in the tumor is the weakness of lymphatic system and the existence of high leakage of 
blood vessels. Also, in both tumor and normal tissues, in the areas where the vessels are closer 
together (higher microvascular density), the IFP is more. In other words, the predicted IFP is 
proportional to the microvascular density and reflects the heterogeneity in the tumor area. The 















non-uniform distribution of IFP in the tumor area. This effect is also reported by Stylianopoulos 
et al. (2013), and Wu et al. (2013). Here, the maximum value of IFP is 2.3 kPa, whereas the 
average value is approximately 1.8 kPa. These value is approximately close to the values 
reported by Boucher et al. (1990), Sefidgar et al. (2015), Soltani et al. (2017), and experimental 
results of Huber et al. (2005).  
  
(a) Intravascular space 
  
(b) Interstitial space 















Velocity distributions in intravascular and interstitial spaces are shown in Figs. 8 (a) and 
(b). Blood velocity has the maximum value of 0.18 m/s in microvessels. As shown in the results, 
the IFV distribution is non-uniform. According to Darcy’s law, in tissues, IFV depends on the 
gradient of IFP. Because IFP distribution is heterogeneous, the gradient of IFP and as a result, 
IFV have non-uniform distribution in tumor area as is reported in the works of Zhao et al. (2007) 
and Pishko et al. (2011). IFV has very low values in the whole computational domain. So, it can 
be said that the convection terms related to the interstitial flow are negligible (Soltani et al., 
2017). In previous works (Zhao et al., 2007; Soltani et al., 2015), it is shown that these terms 
only affect on specific shapes and small sizes of tumors. The maximum value of IFV occurs at 
the tumor boundary, which is almost matched to the presented value of Sefidgar et al. (2015) and 
Pishko et al. (2011), and close to the measured values of Butler et al. (1975).  
  
















(b) Interstitial space 
Fig. 8. Velocity distribution in (a) Intravascular space (b) Interstitial space 
Figs. 9 (a)-(d) show the distribution of CF, CB, CINT, and CTOT, 1-hour after the drug has 
been injected, respectively. The results show that at this time, the value of bounded drug is more 
than the others, which indicates that due to convection and diffusion mechanisms, the free drug 
in ECM is converted to the bounded drug, gradually. In addition, during the same period, 
bounded drug also gradually develops into internalized drug.  
  
















(c) CINT (d) CTOT= CF+CB+CINT 
Fig. 9. Distribution of different drug concentrations (CF, CB, CINT, and CTOT), 1-hour post-injection 
In order to better demonstrate the spatio-temporal variation of drug concentration within 
the tumor, a non-dimensional illustration of different drug concentrations (i.e. CF, CB, CINT, and 
CTOT) are shown in Fig. 10. The values FC , BC , INTC and TOTC  are the dimensionless forms of 
CF, CB, CINT, and CTOT, respectively. Each parameter has been calculated by dividing the related 
concentration at a given point within the geometry by the maximum value of concentration 
within the entire domain, at a designated time. It is worth mentioning that total drug 
concentration is defined as a sum of three concentrations (free, bound, and internalized). In the 
beginning, the drug molecules are located in the blood microvessels but they are quickly 
transmitted to the tissue. After a relatively long time, the drug molecules are transmitted to the 
next regions of the domain through the mechanisms of convection and diffusion. FC  is dominant 
at early time steps. As the time goes ahead, BC  and INTC  are increasing gradually because of 
converting the free drug molecules to the bound and then, internalized molecules by means of 
binding and internalization processes. It is significant that free drug and bound drug 
concentration changes are going in the opposite directions. Also, it is obvious that drug 















maximum value of total concentration occurs in tumor region. This value is several times higher 
than the concentration in the normal tissue around it. The dependency of concentration to the 
vascular network structure is visible, so that, regions with a higher vascular density have a higher 
concentration compared to the other regions which there is no or there are just a few blood 
vessels.  
Time FC  BC  INTC  TOT F B INTC C C C     
0.5-hr 
    
 
1-hr 
    
2-hr 
    
5-hr 
















    
15-hr 
    
20-hr 
    
30-hr 
    
40-hr 
    
 Fig. 10. Spatio-temporal distribution of non-dimensional concentration ( FC , BC , INTC , and TOTC ) at 
different times post-injection. 
 
Fig. 11 represents different time-variant concentration profiles of the drug across the 















investigated in whole domain including tumor and normal tissue. In the beginning, total 
concentration increases with time according to the increase of plasma concentration and the 
source terms of drug extravasation. The maximum amount of average concentration occurs at a 
few minutes post-injection. After the end of the injection, the free and bound concentrations start 
falling immediately. At after approximately 30-hr post-injection, the average drug concentration 
is reached to a constant value. This trend generally exists for free and bound drug concentrations 
in both tumorous and normal tissues. The only difference is that the bound and free drug 
concentrations are reached to zero value. The internalized drug concentration increases over time 
and reaches a constant value after a specified time. By comparing the average concentration in 
tumor and normal tissue regions, it can be concluded that the highest amount of concentration 
occurred in the tumor region. The reason for this phenomenon is the higher permeability of the 
blood vessels in tumor compared to normal tissue.  
  
(a) Tumor (b) Normal tissue 
Fig. 11. Different time-variant concentration profiles of the drug across the (a) Tumor (b) Normal tissue  
To check the concentration changes in the computational domain, five different cut-lines 















the same as in the general trend in Fig. 11, as demonstrated in Fig. 13. Similarly, for cut-lines 5 
and 2, which pass through the center of the tumor, concentration has the maximum values. Cut-
line 4 which located in normal tissue region has the minimum value compared to the other ones. 
Moreover, low density of microvessels can affect the average concentration value so that, the 
value of cut-line 1 is lower than the cut-line 3. Therefore, the cut-lines which located in tumor 
region and also near the well-vascularized regions have the higher amount of concentration. 
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Fig. 13. Variations of different concentrations in five determined cut-lines 
The killing ability of the drug for tumor cells and also, side effects of the drug in 
damaging surrounding tissue play an important role in selecting an efficient chemotherapy drug. 
Fig. 14. shows the fraction of killed cells in the tumor and normal tissue over time during the 
treatment. The overall rate of killed cells is about 78.65% after treatment with doxorubicin. In 















chemotherapy should also be considered. The side effects of drug injection act as a limiting 
factor for drug delivery, because if side effects in a healthy tissue or other tissues exceed a 
specific amount, they will cause serious damage and even gradual death of the tissues and 
ultimately organs. Therefore, the fraction of killed cells for normal tissue is also investigated. 
From Fig. 14, the rate of killed cells for a normal tissue after treatment of doxorubicin is about 
24.94%. It is worth mentioning that the anticancer drug kills both cancer and normal cells 
without any distinction. On the other hand, delivery outcomes of doxorubicin obtained by 
modeling are compared with simulations carried out by Stylianopoulos et al. (2015). Results 
obtained from current modeling for the fraction of killed cells, were in good agreements with 
those reported by (Stylianopoulos et al., 2015). Error between the simulation results and 
literature are mainly due to difference in the geometry of heterogeneous capillary network and 
computational domain, and considering the lymphatic system in tumor region.  
 















By incorporating heterogeneous microvessel’s density in a tumor model, the current 
study has provided more percipience into the influence of non-uniform distribution of the tumor 
microvasculature on drug delivery. The effects of intravascular transport and geometric 
characteristics of tumor microvasculature are also considered. This model takes into account the 
chemotherapy release, its binding, and uptake by cancer cells. In general, results indicate the 
dependency of the drug distribution on both time and space. Also, results show that the 
concentration changes with the microvasculature density. Moreover, the fraction of killed cells is 
presented as a criterion for evaluating the drug efficacy.  
The tumor microenvironment is very complicated to be precisely represented by using a 
single mathematical model. So, the mathematical modeling employed in this study involves 
some assumptions. The main assumption is considering 2-dimensional tumor model instead of a 
full 3-dimensional model. According to the works of Zhan et al. (2014) on the prostate tumor, 
the effect of 3-dimensional on spatial-mean parameters like internalized drug is ignorable. This is 
in agreement with the study of Teo et al. (2005) who found qualitatively the same results 
between 2-dimensional and 3-dimensional models of a brain tumor. A 2-dimensional region is 
also employed in other works such as Jain and co-authors (Stylianopoulos et al., 2013, 2015; 
Mperkis et al., 2017; Stylianopoulos and Jain, 2013), Stephanou and co-authors (2005), Soltani 
and co-authors (2015, 2017, 2018), and Chou et al. (2017). Another assumption is such that the 
uniform transport properties and also, uniform tumor cell density are assumed without 
considering the heterogeneity of intra-or inter-tumor. Moreover, due to using an image as input 
for capillary networks, the authors had to assume the laminar flow in capillaries. In general, 
because of the limitations and the lack of experimental validation, the model predictions 
















The present approach bridges the techniques of image analysis for reconstructing the capillary 
network and CDR modeling for extracting the various measures of fluid properties including 
IFP, IFV, and drug concentration. The coupling mathematical model which solves both blood 
flow in the capillary network, as well as the fluid flow in the interstitial space, is employed to 
calculate the distribution of IFP and IFV. Then, a comprehensive model based on CDR equations 
is used to simulate the drug binding and uptake by tumor cells. Efficacy of anticancer drug and 
also, side effects of the drug on normal tissue are evaluated based on the fraction of killed cells 
parameter by using the predicted intracellular drug concentration. The presented computational 
model provides the necessary first steps toward personalized medicine. By considering such 
image-based model, numerical simulations will shed more light on important mechanisms of 
drug delivery inside the tumor and, simultaneously, suggest a better and more practical 
evaluation of the tumor treatment. The main limitations of current model are: using 2-
dimensional tumor model instead of a full 3-dimensional model, considering static network for 
capillaries, assuming the laminar flow model for blood flow through microvascular network, and 
considering uniform transport properties for normal and tumor tissues. 
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 An imaged-based computational modeling of drug distribution is considered 
 A comprehensive spatio-temporal drug delivery model in tumor and normal tissue is 
developed 
 For more accuracy of the modeling, blood flow and interstitial flow are considered  
 The fraction of killed cells is evaluated both for tumor and normal tissue 
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